8-KLeadership Changes

CARDINAL HEALTH INC 8-K Report, Executive Changes (Aug 5, 2026)

Filed August 5, 2026For Securities:CAH

Summary

Cardinal Health, Inc. (CAH) announced a significant leadership change in its accounting department with the appointment of Anita Zielinski as Chief Accounting Officer, effective November 5, 2026. Ms. Zielinski's appointment follows a period of transition where Mary Scherer will continue in her role until the effective date. This appointment brings a seasoned executive with extensive experience in financial reporting and leadership roles from prominent companies like Baxter International and Sysco Corporation, as well as a background in public accounting at Ernst & Young. Investors should note that Ms. Zielinski's compensation package includes a base salary, bonus potential, and equity awards, along with a $750,000 sign-on bonus and $1,000,000 in restricted share units. This is primarily to compensate for forfeited compensation from her previous employer. The filing also confirms no related-party transactions or disqualifying arrangements concerning Ms. Zielinski's appointment, providing clarity for stakeholders.

Key Highlights

  • 1Anita Zielinski appointed as Chief Accounting Officer (CAO) effective November 5, 2026.
  • 2Mary Scherer will continue as CAO until Ms. Zielinski's effective date.
  • 3Ms. Zielinski joins Cardinal Health from Baxter International, where she held interim CFO and CAO roles.
  • 4Ms. Zielinski has a strong background with over twenty years at Ernst & Young, including partner experience.
  • 5Ms. Zielinski's compensation includes a $750,000 sign-on bonus and a $1,000,000 restricted stock unit grant.
  • 6The sign-on bonus and initial equity grant are primarily to address forfeited compensation from her prior employer.
  • 7No family relationships or reportable transactions under Item 404(a) of Regulation S-K exist between Ms. Zielinski and Company directors/officers.

Frequently Asked Questions

Anita Zielinski has been appointed as the new Chief Accounting Officer of Cardinal Health, Inc. Her appointment is effective November 5, 2026.

Ms. Zielinski brings extensive experience, having served as interim Chief Financial Officer and Senior Vice President, Chief Accounting Officer and Controller at Baxter International. Prior to Baxter, she held senior finance and accounting roles at Sysco Corporation and spent over twenty years in the assurance practice at Ernst & Young, including as a Partner.

The $750,000 cash sign-on bonus and the $1,000,000 initial grant of time-vesting restricted share units are primarily intended to compensate Ms. Zielinski for compensation she forfeited from her previous employer. These equity awards will vest over three years.

The filing states that Ms. Zielinski has no family relationships with any of the Company's directors or executive officers, and there are no arrangements or understandings with any other persons pursuant to which she was selected for this role. Additionally, there are no transactions required to be reported under Item 404(a) of Regulation S-K.